Superior market liquidity and Teucrium's recent launch of a 2x leveraged product could position the anticipated spot XRP ETF for SEC approval

Key Takeaways:

* Superior market liquidity and Teucrium’s recent launch of a 2x leveraged product could position the anticipated spot XRP ETF for SEC approval ahead of competitors Solana (SOL) and Dogecoin (DOGE).

* According to a report by crypto research and data platform Kaiko regarding spot exchange-traded fund (ETF) approval by the US Securities and Exchange Commission, Ripple Labs’ affiliated token leads all other altcoins by the number of ETF filings. XRP has at least 10 different filings, followed by Solana, which is in second place, with filings by five ETF issuers.

* Compared to Bitcoin, whose spot ETF approval by the SEC followed Grayscale’s legal victory, highlighting the regulator’s inconsistency on the futures and spot markets under Gary Gensler’s stewardship, XRP operates in a different way. The Ripple-affiliated token doesn’t run a robust futures market, while its trading volume is mainly offshore.

* XRP’s US spot Market Share has recently surged since the SEC’s 2021 lawsuit triggered delistings. On the other hand, SOL’s US market share has slipped to 16% from a 2022 peak of 25–30% over the same period.

* The launch of a 2x XRP ETF by Teucrium, a US asset manager that mainly tracks European ETPs and swap agreements, has further skyrocketed the spot XRP ETF’s chances for SEC approval. The firm aims to deliver twice XRP’s daily returns. Teucrium Investment Advisors launched a 2x leveraged XRP ETF earlier this month.

* Onchain data shows that the asset manager garnered over $5 million in volumes on debut day to become the provider’s “most successful launch.” As per the report from Kaiko:

“This underlying market’s improving dynamics and the launch of a 2x XRP ETF last week position XRP ahead of other assets when it comes to approval […] although some tokens, such as LTC, which have very similar consensus mechanisms to BTC and share similarities to commodities, could also have a clear path to approval.”

* According to the Kaiko analytical report, May 22 is the next important date to watch, as the SEC must respond to Grayscale’s spot XRP filing by then. The report says:

“Since [Teucrium’s] leveraged ETF relies on returns from European ETPs and swap agreements to guarantee twice the daily returns of XRP, it’s hard to see how a spot product is more risky and therefore diminishes most arguments for denying these applications.”

* Some Cautious Optimism

Surprisingly, with all the positive factors giving the spot XRP ETF SEC approval an advantage over the competition, Deribit’s options market advises for some cautious optimism, highlighting a bearish sentiment relating to implied volatility for April 18 expirations, signalling demand for downside protection. However, Kaiko’s Adam Morgan McCarthy had this to say:

“It’s hard to argue against allowing a spot product when there’s already an active ETF like this, which is highly levered and more risky than a vanilla spot ETF.”

* Records from the federal agency show that several firms are awaiting approval to launch spot crypto ETFs with the U.S. Securities and Exchange Commission. Among the pending applications, the majority of filings for altcoins are for Ripple Labs’ token, XRP, with at least 10 different firms applying to list spot XRP funds.

* The applications for spot XRP ETFs follow other filings for ETPs based on Solana, Litecoin, Cardano, and Dogecoin, among other tokens, reflecting a growing demand for crypto investment products.

* The Kaiko report predicts that after the XRP ETF, the Solana-based fund would be the most likely candidate to receive the green light. The analysis highlights that both applications from Bitwise and Grayscale for a SOL spot ETF have been pending since August 2022.